The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 27, 2019
Filed:
Aug. 07, 2015
Applicant:
Oncoquest Inc., Edmonton, Alberta, CA;
Inventors:
Ragupathy Madiyalakan, Edmonton, CA;
Christopher F Nicodemus, Charlestown, MA (US);
Assignee:
Oncoquest, Inc., Edmonton, Alberta, CA;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); C07K 16/30 (2006.01); A61K 39/395 (2006.01); A61K 31/713 (2006.01); A61K 39/39 (2006.01); C07K 16/10 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/3092 (2013.01); A61K 31/713 (2013.01); A61K 39/39 (2013.01); A61K 39/39558 (2013.01); C07K 16/1063 (2013.01); C07K 16/2827 (2013.01); C07K 16/303 (2013.01); A61K 2039/507 (2013.01); A61K 2039/55561 (2013.01); C07K 2317/21 (2013.01); C07K 2317/30 (2013.01); C07K 2317/34 (2013.01); C07K 2317/56 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01);
Abstract
The present disclosure relates to a method for inhibiting cancer tumor growth in a patient by administering to the patient a therapeutic monoclonal antibody specific for a tumor associated antigen in combination with at least one immunostimulatory compound, and at least one immune homeostatic checkpoint inhibitor. Also disclosed are uses, compositions and kits thereof.